Opioid responsiveness in patients with advanced head and neck cancer

Supportive Care in Cancer

Volumn 6, Issue 5, 1998, Pages 482-485

  Mercadante, Sebastiano ^a  

^a SAMOT Onlus   (Italy)

Author keywords

Cancer pain; Head and neck cancer; Opioid responsiveness

Indexed keywords

CODEINE; DEXTROPROPOXYPHENE; OPIATE; TRAMADOL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER PAIN; CLINICAL ARTICLE; DOSE CALCULATION; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUROPATHY; PAIN ASSESSMENT; PRIORITY JOURNAL;

AGE FACTORS; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NARCOTICS; PAIN; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 0031714620     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050199     Document Type: Article

References (19)

1. Browman GP (1995) Evidence-based recommendations against neoadjuvant chemotherapy in head and neck cancer. Br J Cancer 71:83-91
2. Bruera E, MacMillan K, Hanson J, MacDonald RN (1989) The Edmonton staging system for cancer pain: preliminary report. Pain 37:203-209
3. Bruera E, Schoeller T, Wenk R, MacEachern T, Marcelino S, Hanson J, Suarez-Almazor (1995) A prospective multicenter assessment of the Edmonton staging sytsem for cancer pain. J Pain Symptom Manage 10:348-355
4. De Conno F, Barletta L, Milani S, Ripamonti C, Tamburini M, Ventafridda V (1990) Révision des résultats du traitement antalgique par la morphine oreale vs-à-vis de différentes pathologies oncologiques. Douleur Analg 3:55-57
5. Droughton ML (1990) Head and neck carcinomas. J Palliat Care 6:43-46
6. Grond S, Zech D, Lynch J, Diefenbach C, Schug SA, Lehmann KA (1993) Validation of World Health Organization guidelines for pain relief in head and neck cancer. A prospective study. Ann Otol Rhinol Laryngol 102:342-348
7. Hanks GW, Justins DM (1992) Cancer pain: management. Lancet 339:1031-1036
8. Jadad AR, Carroll D, Glynn CJ, Moore RA, McQuay HJ (1992) Morphine responsiveness of chronic pain: double blind randomized crossover study with patient-controlled analgesia. Lancet 339:1367-1371
9. Mercadante S, Maddaloni S, Roccella S, Salvaggio L (1992) Predictive factors in advanced cancer pain treated only by analgesics. Pain 50:151-155
10. Mercadante S, Pumo G, Salvaggio L, Agnello A, Genovese G, Garofalo S (1996) Opioid responsiveness in lung cancer pain patients. Pain Clin 9:409-418
11. Mercadante S, Dardanoni G, Salvaggio L, Armata MG, Agnello A (1997) Monitoring of opioid therapy in advanced cancer pain patients. J Pain Symptom Manage 13:204-212
12. Mercadante S, Sapio M, Caligara M, Serretta R, Dardanoni G, Barresi L (1997) Opioid-sparing effect of diclofenac in cancer pain. J Pain Symptom Manage 14:15-20
13. Portenoy RK (1992) Cancer pain: pathophysiolosy and syndromes. Lancet 339:1026-1031
14. Portenoy RK, Foley KM, Inturrisi CE (1990) The neture of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 43:273-286
15. Saxena A, Gnanasekaran N, Andley M (1995) An epidemiological study of prevalence of pain in head and neck cancers. Indian J Med Res 102:28-33
16. Silverberg E. Borring CC, Squires TS (1990) Cancer statistics. CA Cancer J Clin 40:9-26
17. Spitz MR (1994) Epidemiology and risk factors for head and neck cancer. Semin Oncol 21:281-288
18. Talmi YP, Waller A, Bercovici M, Horowitz Z, Pfeffer MR, Adunski A, Kronenberg J (1997) Pain experienced by patients with terminal head and neck carcinoma. Cancer 80:1117-1123
19. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Medical progress: head and neck cancer. N Engl J Med 328:184-194